219 related articles for article (PubMed ID: 22669455)
21. Photoacoustic Molecular Imaging for the Identification of Lymph Node Metastasis in Head and Neck Cancer Using an Anti-EGFR Antibody-Dye Conjugate.
Nishio N; van den Berg NS; Martin BA; van Keulen S; Fakurnejad S; Rosenthal EL; Wilson KE
J Nucl Med; 2021 May; 62(5):648-655. PubMed ID: 33008927
[TBL] [Abstract][Full Text] [Related]
22. Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma.
van Keulen S; van den Berg NS; Nishio N; Birkeland A; Zhou Q; Lu G; Wang HW; Middendorf L; Forouzanfar T; Martin BA; Colevas AD; Rosenthal EL
Oral Oncol; 2019 Jan; 88():58-65. PubMed ID: 30616798
[TBL] [Abstract][Full Text] [Related]
23. In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence.
Rosenthal EL; Kulbersh BD; Duncan RD; Zhang W; Magnuson JS; Carroll WR; Zinn K
Laryngoscope; 2006 Sep; 116(9):1636-41. PubMed ID: 16954995
[TBL] [Abstract][Full Text] [Related]
24. Molecular imaging of a fluorescent antibody against epidermal growth factor receptor detects high-grade glioma.
Zhou Q; Vega Leonel JCM; Santoso MR; Wilson C; van den Berg NS; Chan CT; Aryal M; Vogel H; Cayrol R; Mandella MJ; Schonig F; Lu G; Gambhir SS; Moseley ME; Rosenthal EL; Grant GA
Sci Rep; 2021 Mar; 11(1):5710. PubMed ID: 33707521
[TBL] [Abstract][Full Text] [Related]
25. Near-infrared fluorescence imaging-guided surgery improves recurrence-free survival rate in novel orthotopic animal model of head and neck squamous cell carcinoma.
Atallah I; Milet C; Henry M; Josserand V; Reyt E; Coll JL; Hurbin A; Righini CA
Head Neck; 2016 Apr; 38 Suppl 1():E246-55. PubMed ID: 25546527
[TBL] [Abstract][Full Text] [Related]
26. Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model.
Gleysteen JP; Newman JR; Chhieng D; Frost A; Zinn KR; Rosenthal EL
Head Neck; 2008 Jun; 30(6):782-9. PubMed ID: 18228526
[TBL] [Abstract][Full Text] [Related]
27. The Sentinel Margin: Intraoperative
van Keulen S; Nishio N; Birkeland A; Fakurnejad S; Martin B; Forouzanfar T; Cunanan K; Colevas AD; S van den Berg N; Rosenthal E
Clin Cancer Res; 2019 Aug; 25(15):4656-4662. PubMed ID: 31142505
[TBL] [Abstract][Full Text] [Related]
28. Fluorescence molecular imaging for identification of high-grade dysplasia in patients with head and neck cancer.
Fakurnejad S; van Keulen S; Nishio N; Engelen M; van den Berg NS; Lu G; Birkeland A; Baik F; Colevas AD; Rosenthal EL; Martin BA
Oral Oncol; 2019 Oct; 97():50-55. PubMed ID: 31421471
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.
Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265
[TBL] [Abstract][Full Text] [Related]
30. Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers.
Gao RW; Teraphongphom N; de Boer E; van den Berg NS; Divi V; Kaplan MJ; Oberhelman NJ; Hong SS; Capes E; Colevas AD; Warram JM; Rosenthal EL
Theranostics; 2018; 8(9):2488-2495. PubMed ID: 29721094
[No Abstract] [Full Text] [Related]
31. Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW.
Krishnan G; van den Berg NS; Nishio N; Juniper G; Pei J; Zhou Q; Lu G; Lee YJ; Ramos K; Iagaru AH; Baik FM; Colevas AD; Martin BA; Rosenthal EL
Theranostics; 2021; 11(15):7188-7198. PubMed ID: 34158844
[No Abstract] [Full Text] [Related]
32. Rapid molecular detection of metastatic head and neck squamous cell carcinoma as an intraoperative adjunct to sentinel lymph node biopsy.
Ferris RL; Stefanika P; Xi L; Gooding W; Seethala RR; Godfrey TE
Laryngoscope; 2012 May; 122(5):1020-30. PubMed ID: 22447185
[TBL] [Abstract][Full Text] [Related]
33. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A
Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488
[TBL] [Abstract][Full Text] [Related]
34. Optical imaging predicts tumor response to anti-EGFR therapy.
Helman EE; Newman JR; Dean NR; Zhang W; Zinn KR; Rosenthal EL
Cancer Biol Ther; 2010 Jul; 10(2):166-71. PubMed ID: 20505368
[TBL] [Abstract][Full Text] [Related]
35. Determination of Tumor Margins with Surgical Specimen Mapping Using Near-Infrared Fluorescence.
Gao RW; Teraphongphom NT; van den Berg NS; Martin BA; Oberhelman NJ; Divi V; Kaplan MJ; Hong SS; Lu G; Ertsey R; Tummers WSFJ; Gomez AJ; Holsinger FC; Kong CS; Colevas AD; Warram JM; Rosenthal EL
Cancer Res; 2018 Sep; 78(17):5144-5154. PubMed ID: 29967260
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.
Ferris RL; Geiger JL; Trivedi S; Schmitt NC; Heron DE; Johnson JT; Kim S; Duvvuri U; Clump DA; Bauman JE; Ohr JP; Gooding WE; Argiris A
Ann Oncol; 2016 Dec; 27(12):2257-2262. PubMed ID: 27733374
[TBL] [Abstract][Full Text] [Related]
37. Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients.
Trivedi S; Srivastava RM; Concha-Benavente F; Ferrone S; Garcia-Bates TM; Li J; Ferris RL
Clin Cancer Res; 2016 Nov; 22(21):5229-5237. PubMed ID: 27217441
[TBL] [Abstract][Full Text] [Related]
38. Activatable fluorescence detection of epidermal growth factor receptor positive mediastinal lymph nodes in murine lung cancer model.
Zhang X; Nakajima T; Kim M; Yamaguchi A; Lamid-Ochir O; Nguyen-Thu H; Bhattarai A; Hanaoka H; Tsushima Y
PLoS One; 2018; 13(6):e0198224. PubMed ID: 29856819
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor-targeted radioimmunotherapy of human head and neck cancer xenografts using 90Y-labeled fully human antibody panitumumab.
Liu Z; Liu Y; Jia B; Zhao H; Jin X; Li F; Chen X; Wang F
Mol Cancer Ther; 2010 Aug; 9(8):2297-308. PubMed ID: 20682654
[TBL] [Abstract][Full Text] [Related]
40. Panitumumab-IRDye800 Improves Laryngeal Tumor Mapping During Transoral Laser Microsurgery.
Bailey L; Stone LD; Gonzalez ML; Thomas CM; Jeyarajan H; Warram JM; Panuganti B
Laryngoscope; 2024 Apr; 134(4):1837-1841. PubMed ID: 37860983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
